Leading cancer patient advocate kelly shanahan, m.d., joins jaguar health's scientific advisory board

San francisco, ca / accesswire / march 23, 2023 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") and its wholly owned subsidiary napo pharmaceuticals (napo) today announced that dr. kelly shanahan, a former clinician and a metastatic breast cancer patient who is now a full-time independent patient advocate, has joined the jaguar/napo scientific advisory board (sab). "we are very pleased that dr. shanahan has joined our sab," said pravin chaturvedi, phd, napo and jaguar's chair of the scientific advisory board and chief scientific officer.
JAGX Ratings Summary
JAGX Quant Ranking